top of page

Stay Up to Date!

For the most updated publication list, check out Dr. Alexander-Bryant on PubMed.

2026

​22/ Barnett, E, Lavalla, J, Thatavarthi, P, Ray, I, Hamas, T, Jager, J, Kanduri, V, White, J, Singleton, E, Drinks, J, Pitz, M, Alexander-Bryant, A, Larsen, J. Enabling in vivo imaging in low-resource settings: Computed tomography imaging of gold-loaded polymersomes for the detection of glioblastoma. Bioeng Transl Med. 2026; e70109. doi: 10.1002/btm2.70109

2025

21 / Yadav, N, Boulos, J, Alexander-Bryant, A, Cook, K. Stochastic model of siRNA endosomal escape mediated by fusogenic peptides. Math Biosci. 2025 Jun 5;387:109476. doi: 10.1016/j.mbs.2025.109476. Epub ahead of print. PMID: 40482915.
20 / Alatise, K.L., Samec, T, Coffin, C, Gilmore, S, Hazelton, A, Xia, R, Jones, C, Alexander-Bryant, A. Multifunctional Tandem Peptide Mediates Targeted siRNA Delivery to Ovarian Cancer Cells. ACS Appl Bio Mater. 2025 Jun 16;8(6):4612-4620. doi: 10.1021/acsabm.4c01545. Epub 2025 Jun 4. PMID: 40465375.
19 / Eckert, T, Zobaer, M.S., Boulos, J, Alexander-Bryant, A, Baker, T.G., Rivers, C, Das, A, Vandergrift, W.A., Martinez, J, Zukas, A, Lindhorst, S.M., Patel, S, Strickland, B, Rowland, N.C. Immune Resistance in Glioblastoma: Understanding the Barriers to ICI and CAR-T Cell Therapy. Cancers (Basel). 2025 Jan 29;17(3):462. doi: 10.3390/cancers17030462. PMID: 39941829; PMCID: PMC11816167.

2024

18 / Attia, M.F., Ogunnaike, E.A., Pitz, M, Elbaz, N.M., Panda, D.K., Alexander-Bryant, A, Saha, S, Whitehead, D.C., Kabanov, A. Enhancing drug delivery with supramolecular amphiphilic macrocycle nanoparticles: selective targeting of CDK4/6 inhibitor palbociclib to melanoma. Biomaterials Science. 2024 Jan 30;12(3):725-737.11. doi: 10.1039/d3bm01888a. PMID: 38099834; PMCID: PMC10872447.

2022

17 / Alatise, K.L., Gardner, S, Alexander-Bryant, A. Mechanisms of Drug Resistance in Ovarian Cancer and Associated Gene Targets. Cancers (Basel). 2022 Dec 18;14(24):6246. doi: 10.3390/cancers14246246. PMID: 36551731; PMCID: PMC9777152.
16 / Samec, T, Alatise, K.L, Boulos, J, Gilmore, S, Hazelton, A, Coffin, C, Alexander-Bryant, A. Fusogenic peptide delivery of bioactive siRNAs targeting CSNK2A1 for treatment of ovarian cancer. Mol Ther Nucleic Acids. 2022 Sep 19;30:95-111. doi: 10.1016/j.omtn.2022.09.012. PMID: 36213692; PMCID: PMC9530961.
14 / Pitz, M, Elpers, M, Nukovic, A, Wilde, S, Gregory, A.J., Alexander-Bryant, A. De Novo Self-Assembling Peptides Mediate the Conversion of Temozolomide and Delivery of a Model Drug into Glioblastoma Multiforme Cells. Biomedicines. 2022 Sep 2;10(9):2164. doi: 10.3390/biomedicines10092164. PMID: 36140265; PMCID: PMC9495814.
13 / Samec, T, Boulos, J, Gilmore, S, Hazelton, A, Alexander-Bryant, A. Peptide-based delivery of therapeutics in cancer treatment. Mater Today Bio. 2022 Mar 30;14:100248. doi: 10.1016/j.mtbio.2022.100248. PMID: 35434595; PMCID: PMC9010702.
12 / Pitz, M.E., Nukovic, A.M., Elpers, M.A., Alexander-Bryant, A.A. Factors Affecting Secondary and Supramolecular Structures of Self-Assembling Peptide Nanocarriers. Macromol Biosci. 2022 Feb;22(2):e2100347. doi: 10.1002/mabi.202100347. PMID: 3480000.

2021

11 / Attia, M, Montaser A.S., Arifuzzaman, M, Pitz, M, Jlassi, K, Alexander-Bryant, A, Kelly, S.S., Alexis, F, Whitehead, D.C., 2021. In situ Photopolymerization of Acrylamide Hydrogel to Coat Cellulose Acetate Nanofibers for Drug Delivery System. Polymers 2021, 13(11), 1863. doi: 10.3390/polym13111863. PMID: 34205186; PMCID: PMC8200032.
10 / Miller, E.M., Samec ,T.M., Alexander-Bryant, A.A. Nanoparticle delivery systems to combat drug resistance in ovarian cancer. Nanomedicine. 2021 Jan;31:102309. doi: 10.1016/j.nano.2020.102309. PMID: 32992019.

2020

9 / Mbiki, S., McClendon, J., Alexander-Bryant, A., & Gilmore, J. (2020). Classifying changes in LN-18 glial cell morphology: a supervised machine learning approach to analyzing cell microscopy data via FIJI and WEKA. Medical & biological engineering & computing, 58(7), 1419–1430. doi: 10.1007/s11517-020-02177-x. PMID: 32314170.
8 / Iqbal, S., Blenner, M., Alexander-Bryant, A., & Larsen, J. (2020). Polymersomes for Therapeutic Delivery of Protein and Nucleic Acid Macromolecules: From Design to Therapeutic Applications. Biomacromolecules, 21(4), 1327–1350. doi: 10.1021/acs.biomac.9b01754. PMID: 32078290.

2019

7 / Caffery, B., Lee, J. S., & Alexander-Bryant, A. A. (2019). Vectors for Glioblastoma Gene Therapy: Viral & Non-Viral Delivery Strategies. Nanomaterials (Basel, Switzerland), 9(1), 105. doi: 10.3390/nano9010105. PMID: 30654536; PMCID: PMC6359729.

2017

6 / Alexander-Bryant, A, Zhang, H, Attaway, C, Pugh, W, Eggart, L, Sansevere, R, Andino, L, Dinh, Lu, Cantini, L, Jakymiw, A, 2017. Dual peptide-mediated targeted delivery of bioactive siRNAs to oral cancer cells in vivo. Oral Oncology, 72: 123-131. doi: 10.1016/j.oraloncology.2017.07.004. PMID: 28797448; PMCID: PMC5580030.
5 / Alexander-Bryant, A, Hourigan, B, Lynn, M, Lee, JS, “Nanotherapeutics for combination drug and gene therapy in treating glioblastoma multiforme,” Proceedings: AACR 108th Annual Meeting 2017, American Association for Cancer Research, Washington, DC (April 2017).

2016

4 / Alexander-Bryant, A, Zhang, H, Pugh, W, Dinh, Lu, Attaway, C, Laurence, E, Sansevere, R, Jakymiw, A. “Dual peptide-mediated targeted delivery of siRNAs for the treatment of oral cancer,” Proceedings: AACR 107th Annual Meeting 2016, American Association for Cancer Research, New Orleans, LA (April 2016).

2015

3 / Alexander-Bryant, A, Dumitriu, A, Attaway, C, Yu, H, Jakymiw, A, 2015. Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo. Journal of Controlled Release, 218: 72-81. doi: 10.1016/j.jconrel.2015.09.026. PMID: 26386438; PMCID: PMC4646222.
2 / Alexander-Bryant, A, Dumitriu, A, Attaway, C, Yu, H, Jakymiw, A. “Fusogenic-oligoarginine peptide-mediated silencing of the CIP2A oncogene suppresses oral cancer tumor growth in vivo,” Proceedings: AACR 106th Annual Meeting 2015, American Association for Cancer Research, Philadelphia, PA (April 2015).

2013

1 / Alexander-Bryant, A.A., Vanden Berg-Foels, W.S., Wen, X, 2013. Bioengineering strategies for designing targeted cancer therapies. Advances in Cancer Research 118, 1-59. doi: 10.1016/B978-0-12-407173-5.00002-9. PMID: 23768509; PMCID: PMC4165503.

bottom of page